Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.

Aggarwal S, Liu X, Rice C, Menell P, Clark PJ, Paparoidamis N, Xiao YC, Salvino JM, Fontana ACK, España RA, Kortagere S, Mortensen OV.

ACS Chem Neurosci. 2019 Jun 24. doi: 10.1021/acschemneuro.9b00262. [Epub ahead of print]

PMID:
31184115
2.

Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.

Marshall CA, Brodnik ZD, Mortensen OV, Reith MEA, Shumsky JS, Waterhouse BD, España RA, Kortagere S.

Neuropharmacology. 2019 Apr;148:178-188. doi: 10.1016/j.neuropharm.2019.01.003. Epub 2019 Jan 8.

PMID:
30633928
3.

Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse.

Mahler SV, Brodnik ZD, Cox BM, Buchta WC, Bentzley BS, Quintanilla J, Cope ZA, Lin EC, Riedy MD, Scofield MD, Messinger J, Ruiz CM, Riegel AC, España RA, Aston-Jones G.

J Neurosci. 2019 Jan 16;39(3):503-518. doi: 10.1523/JNEUROSCI.0537-18.2018. Epub 2018 Nov 16.

4.

Local GABAA Receptor-Mediated Suppression of Dopamine Release within the Nucleus Accumbens.

Brodnik ZD, Batra A, Oleson EB, España RA.

ACS Chem Neurosci. 2019 Apr 17;10(4):1978-1985. doi: 10.1021/acschemneuro.8b00268. Epub 2018 Oct 10.

PMID:
30253088
5.

The histone demethylase KDM6B in the medial prefrontal cortex epigenetically regulates cocaine reward memory.

Zhang YX, Akumuo RC, España RA, Yan CX, Gao WJ, Li YC.

Neuropharmacology. 2018 Oct;141:113-125. doi: 10.1016/j.neuropharm.2018.08.030. Epub 2018 Aug 27.

PMID:
30165076
6.

Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights.

Brodnik ZD, Alonso IP, Xu W, Zhang Y, Kortagere S, España RA.

Brain Res. 2018 Jul 30. pii: S0006-8993(18)30410-4. doi: 10.1016/j.brainres.2018.07.027. [Epub ahead of print] Review.

PMID:
30071195
7.

Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome.

Murphy MM, Lindsey Burrell T, Cubells JF, España RA, Gambello MJ, Goines KCB, Klaiman C, Li L, Novacek DM, Papetti A, Sanchez Russo RL, Saulnier CA, Shultz S, Walker E, Mulle JG.

BMC Psychiatry. 2018 Jun 8;18(1):183. doi: 10.1186/s12888-018-1760-5.

8.

Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.

Struzyna LA, Browne KD, Brodnik ZD, Burrell JC, Harris JP, Chen HI, Wolf JA, Panzer KV, Lim J, Duda JE, España RA, Cullen DK.

J Tissue Eng Regen Med. 2018 Jul;12(7):1702-1716. doi: 10.1002/term.2698. Epub 2018 Jun 3.

9.

Diazepam Concurrently Increases the Frequency and Decreases the Amplitude of Transient Dopamine Release Events in the Nucleus Accumbens.

Schelp SA, Brodnik ZD, Rakowski DR, Pultorak KJ, Sambells AT, España RA, Oleson EB.

J Pharmacol Exp Ther. 2018 Jan;364(1):145-155. doi: 10.1124/jpet.117.241802. Epub 2017 Oct 20.

10.

Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine.

Bernstein DL, Badve PS, Barson JR, Bass CE, España RA.

Addict Biol. 2018 Sep;23(5):1032-1045. doi: 10.1111/adb.12553. Epub 2017 Oct 2.

PMID:
28971565
11.

Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Brodnik ZD, Black EM, Clark MJ, Kornsey KN, Snyder NW, España RA.

Neuropharmacology. 2017 Oct;125:295-307. doi: 10.1016/j.neuropharm.2017.07.032. Epub 2017 Aug 1.

12.

Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling.

Levy KA, Brodnik ZD, Shaw JK, Perrey DA, Zhang Y, España RA.

Psychopharmacology (Berl). 2017 Sep;234(18):2761-2776. doi: 10.1007/s00213-017-4673-y. Epub 2017 Jun 30.

13.

L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Brodnik ZD, Double M, España RA, Jaskiw GE.

Neuropharmacology. 2017 Sep 1;123:159-174. doi: 10.1016/j.neuropharm.2017.05.030. Epub 2017 May 29.

14.

Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.

Escobar AP, González MP, Meza RC, Noches V, Henny P, Gysling K, España RA, Fuentealba JA, Andrés ME.

Int J Neuropsychopharmacol. 2017 Aug 1;20(8):660-669. doi: 10.1093/ijnp/pyx042.

15.

Pharmacologically increasing microtubule acetylation corrects stress-exacerbated effects of organophosphates on neurons.

Rao AN, Patil A, Brodnik ZD, Qiang L, España RA, Sullivan KA, Black MM, Baas PW.

Traffic. 2017 Jul;18(7):433-441. doi: 10.1111/tra.12489. Epub 2017 May 25.

16.

Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine.

Gentile TA, Simmons SJ, Barker DJ, Shaw JK, España RA, Muschamp JW.

Addict Biol. 2018 Jan;23(1):247-255. doi: 10.1111/adb.12507. Epub 2017 Apr 17.

17.

Reinforcing Doses of Intravenous Cocaine Produce Only Modest Dopamine Uptake Inhibition.

Brodnik ZD, Ferris MJ, Jones SR, España RA.

ACS Chem Neurosci. 2017 Feb 15;8(2):281-289. doi: 10.1021/acschemneuro.6b00304. Epub 2016 Dec 29.

18.

Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.

MacLaren DA, Browne RW, Shaw JK, Krishnan Radhakrishnan S, Khare P, España RA, Clark SD.

eNeuro. 2016 Nov 1;3(5). pii: ENEURO.0219-16.2016. eCollection 2016 Sep-Oct.

19.

Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine.

Shaw JK, Ferris MJ, Locke JL, Brodnik ZD, Jones SR, España RA.

Addict Biol. 2017 Nov;22(6):1695-1705. doi: 10.1111/adb.12432. Epub 2016 Aug 2.

20.

Norepinephrine at the nexus of arousal, motivation and relapse.

España RA, Schmeichel BE, Berridge CW.

Brain Res. 2016 Jun 15;1641(Pt B):207-16. doi: 10.1016/j.brainres.2016.01.002. Epub 2016 Jan 7. Review.

21.

The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats.

Bernosky-Smith KA, Stanger DB, Trujillo AJ, Mitchell LR, España RA, Bass CE.

Pharmacol Biochem Behav. 2016 Mar;142:48-55. doi: 10.1016/j.pbb.2015.12.007. Epub 2015 Dec 15.

22.

Dopamine uptake dynamics are preserved under isoflurane anesthesia.

Brodnik ZD, España RA.

Neurosci Lett. 2015 Oct 8;606:129-34. doi: 10.1016/j.neulet.2015.08.046. Epub 2015 Aug 28.

23.

Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.

Escobar AP, Cornejo FA, Olivares-Costa M, González M, Fuentealba JA, Gysling K, España RA, Andrés ME.

J Neurochem. 2015 Sep;134(6):1081-90. doi: 10.1111/jnc.13209. Epub 2015 Jul 14.

24.

Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep.

Brodnik ZD, Bernstein DL, Prince CD, España RA.

Behav Brain Res. 2015 Sep 15;291:377-384. doi: 10.1016/j.bbr.2015.05.051. Epub 2015 Jun 3.

25.

Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1.

Prince CD, Rau AR, Yorgason JT, España RA.

ACS Chem Neurosci. 2015 Jan 21;6(1):138-46. doi: 10.1021/cn500246j. Epub 2014 Dec 11.

26.

Dopamine transporters govern diurnal variation in extracellular dopamine tone.

Ferris MJ, España RA, Locke JL, Konstantopoulos JK, Rose JH, Chen R, Jones SR.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2751-9. doi: 10.1073/pnas.1407935111. Epub 2014 Jun 16.

27.

Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling.

Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ.

Eur J Neurosci. 2014 Jul;40(1):2255-63. doi: 10.1111/ejn.12594. Epub 2014 Apr 23.

28.

Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals.

Ferris MJ, Calipari ES, Melchior JR, Roberts DC, España RA, Jones SR.

Eur J Neurosci. 2013 Aug;38(4):2628-36. doi: 10.1111/ejn.12266. Epub 2013 Jun 3.

29.

Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats.

Yorgason JT, España RA, Konstantopoulos JK, Weiner JL, Jones SR.

Eur J Neurosci. 2013 Mar;37(6):1022-31. doi: 10.1111/ejn.12113. Epub 2013 Jan 8.

30.

Presynaptic dopamine modulation by stimulant self-administration.

Espana RA, Jones SR.

Front Biosci (Schol Ed). 2013 Jan 1;5:261-76. Review.

31.

Hypocretin/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms.

Calipari ES, España RA.

Front Behav Neurosci. 2012 Aug 21;6:54. doi: 10.3389/fnbeh.2012.00054. eCollection 2012.

32.

Hypocretin/orexin involvement in reward and reinforcement.

España RA.

Vitam Horm. 2012;89:185-208. doi: 10.1016/B978-0-12-394623-2.00010-X. Review.

33.

Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.

Oleson EB, Ferris MJ, España RA, Harp J, Jones SR.

Eur J Pharmacol. 2012 May 15;683(1-3):161-5. doi: 10.1016/j.ejphar.2012.03.003. Epub 2012 Mar 15.

34.

Noradrenergic modulation of wakefulness/arousal.

Berridge CW, Schmeichel BE, España RA.

Sleep Med Rev. 2012 Apr;16(2):187-97. doi: 10.1016/j.smrv.2011.12.003. Epub 2012 Jan 31. Review.

35.

Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference.

McGinty VB, Hayden BY, Heilbronner SR, Dumont EC, Graves SM, Mirrione MM, du Hoffmann J, Sartor GC, España RA, Millan EZ, Difeliceantonio AG, Marchant NJ, Napier TC, Root DH, Borgland SL, Treadway MT, Floresco SB, McGinty JF, Haber S.

Behav Brain Res. 2011 Nov 20;225(1):348-57. doi: 10.1016/j.bbr.2011.07.036. Epub 2011 Jul 26. Review.

36.

Sleep neurobiology from a clinical perspective.

España RA, Scammell TE.

Sleep. 2011 Jul 1;34(7):845-58. doi: 10.5665/SLEEP.1112. Review.

37.

Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection.

Yorgason JT, Jones SR, España RA.

Neuroscience. 2011 May 19;182:125-32. doi: 10.1016/j.neuroscience.2011.03.017. Epub 2011 Mar 21.

38.

Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures.

Yorgason JT, España RA, Jones SR.

J Neurosci Methods. 2011 Nov 15;202(2):158-64. doi: 10.1016/j.jneumeth.2011.03.001. Epub 2011 Mar 8.

39.

Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration.

España RA, Melchior JR, Roberts DC, Jones SR.

Psychopharmacology (Berl). 2011 Mar;214(2):415-26. doi: 10.1007/s00213-010-2048-8. Epub 2010 Oct 20.

40.

The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system.

España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR.

Eur J Neurosci. 2010 Jan;31(2):336-48. doi: 10.1111/j.1460-9568.2009.07065.x. Epub 2009 Dec 23.

41.

Hypocretin/orexin in arousal and stress.

Berridge CW, España RA, Vittoz NM.

Brain Res. 2010 Feb 16;1314:91-102. doi: 10.1016/j.brainres.2009.09.019. Epub 2009 Sep 11. Review.

42.

Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.

Hampson RE, España RA, Rogers GA, Porrino LJ, Deadwyler SA.

Psychopharmacology (Berl). 2009 Jan;202(1-3):355-69. doi: 10.1007/s00213-008-1360-z. Epub 2008 Nov 5.

43.

Coping behavior causes asymmetric changes in neuronal activation in the prefrontal cortex and amygdala.

Stalnaker TA, España RA, Berridge CW.

Synapse. 2009 Jan;63(1):82-5. doi: 10.1002/syn.20583.

44.

Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery.

España RA, Roberts DC, Jones SR.

Neuroscience. 2008 Jul 31;155(1):250-7. doi: 10.1016/j.neuroscience.2008.05.022. Epub 2008 Jul 1.

45.

Running promotes wakefulness and increases cataplexy in orexin knockout mice.

España RA, McCormack SL, Mochizuki T, Scammell TE.

Sleep. 2007 Nov;30(11):1417-25.

46.

Organization of noradrenergic efferents to arousal-related basal forebrain structures.

España RA, Berridge CW.

J Comp Neurol. 2006 Jun 10;496(5):668-83.

PMID:
16615125
47.

Afferents to the orexin neurons of the rat brain.

Yoshida K, McCormack S, España RA, Crocker A, Scammell TE.

J Comp Neurol. 2006 Feb 10;494(5):845-61.

48.

Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E, Scammell TE.

Neurology. 2005 Oct 25;65(8):1184-8. Epub 2005 Sep 14.

49.

Hypocretins: waking, arousal, or action?

Berridge CW, España RA.

Neuron. 2005 Jun 2;46(5):696-8. Review.

50.

Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures.

España RA, Reis KM, Valentino RJ, Berridge CW.

J Comp Neurol. 2005 Jan 10;481(2):160-78.

PMID:
15562511

Supplemental Content

Loading ...
Support Center